Quantitative determination of (−)-2′-deoxy-3′-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection

This publication has 12 references indexed in Scilit:

• Lamivudine in Children with Human Immunodeficiency Virus Infection: A Phase I/II Study
  The Journal of Infectious Diseases, 1996
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients
  AIDS, 1995
• Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
  The Journal of Infectious Diseases, 1995
• Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients
  The Lancet, 1995
• The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine
  Journal of Pharmaceutical and Biomedical Analysis, 1994
• High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serum
  Journal of Chromatography B: Biomedical Sciences and Applications, 1994
• Automated high-performance liquid chromatographic analysis of (−)-2′-deoxy-3′-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems
  Journal of Chromatography B: Biomedical Sciences and Applications, 1994
• Determination of 2′-deoxy-3′-thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switching
  Journal of Pharmaceutical and Biomedical Analysis, 1994
• Calibration and validation of linearity in chromatographic biopharmaceutical analysis
  Journal of Pharmaceutical and Biomedical Analysis, 1991